Cellebrite Stock Upgraded by BofA: Buy Now!by Mark Eisenberg 16.02.2024Bank of America Securities upgrades Cellebrite stock to Buy, increasing price target to $12. Improved business momentum and strong market ...
Biohaven Pharmaceutical: RBC’s $62 Target and Growthby Mark Eisenberg 16.02.2024RBC Capital Markets initiates coverage on Biohaven Pharmaceutical, assigning an outperform rating with a $62 price target. The firm praises ...
Amazon’s Bezos Sells $2B Shares Amid Layoffs Wave: Stock Market Movesby Mark Eisenberg 16.02.2024Amazon.com Executive Chair Jeffrey P Bezos sells over $2 billion in shares, while Royal Caribbean Cruises CEO sells shares worth ...
Global Equity Funds: $59.5B Surge Raises Concernsby Terry Bingman 16.02.2024Global equity funds have surged with $59.5 billion in inflows over the past four weeks, but concerns arise over the ...
Aurinia Pharmaceuticals Faces Downgrade, Halts Drug Developmentby Mark Eisenberg 16.02.2024Aurinia Pharmaceuticals downgraded by Bloom Burton & Co. as they halt drug development and implement workforce reduction. Implications for future ...
Opendoor Technologies Inc. Q4 Revenue Surges to $870M.by Mark Eisenberg 16.02.2024Opendoor Technologies Inc. reported strong Q4 performance, with revenue reaching $870M and a solid contribution margin. The company anticipates growth ...
Dropbox Stumbles: Revenue Beat, Stock Tumblesby Mark Eisenberg 16.02.2024Dropbox's Q4 earnings beat expectations with higher EPS and revenue, but concerns over declining ARR and paying users caused a ...
Atria Wealth Solutions Invests Big in AI, Robotics ETFby Terry Bingman 16.02.2024Atria Wealth Solutions Inc. has increased its stake in the First Trust Nasdaq Artificial Intelligence and Robotics ETF, along with ...
Coinbase Surges on Bitcoin ETF Buzz: Hits 2023 Peakby John Darbie 16.02.2024Coinbase Global shares rise 12% on optimism around bitcoin ETFs, leading to the company's first profit since 2021. Increased investor ...
Russian Rouble Tumbles After Navalny’s Deathby Mark Eisenberg 16.02.2024The Russian rouble weakened after news of opposition politician Alexei Navalny's death, along with the central bank's decision to keep ...